Do biopharma companies take the right approach with cancer patients?

Do biopharma companies take the right approach with cancer patients?

Biopharma companies need to start conversations with patients as early as in Phase I during the drug development process and, most importantly, maintain a feedback loop with patients throughout the whole development process.  

Source: http://bit.ly/2QopqW6